secwatch.observer — SEC 8-K summary
======================================

Issuer:     NovoCure Ltd (NVCR)
CIK:        0001645113
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0001645113-25-000011
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NovoCure shareholders elect 11 directors, approve ESPP; President awarded 179,426 RSUs
--------------------------------------------------------------------------------

- Shareholders elected all 11 director nominees with >81M votes each; 92.98M shares represented (~83.4%).
- Say-on-pay approved: 80.6M for, 2.0M against, ~10M broker non-votes.
- 2025 Employee Share Purchase Plan approved: 82.0M for, 0.68M against; reserves 6,507,843 shares (less prior plan shares).
- Francis Leonard appointed President, Novocure and awarded 179,426 RSUs vesting in two equal annual installments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645113/000164511325000011/0001645113-25-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645113/000164511325000011/nvcr-20250604.htm
  HTML page:      https://secwatch.observer/filing/0001645113-25-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer